Skip to Content

View Additional Section Content

NRG-GY007 A Phase I/II Study of Ruxolitinib with Front-Line Neoadjuvant and Post-Surgical Therapy in Patients with Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT02713386?term=gy007&rank=1

Clinical Trial Categories

  • Ovarian Cancer
Contact
Ashley Douglas, RN at 215-481-4429

Location

  • Asplundh Cancer Pavilion
    3941 Commerce Ave.
    Willow Grove, PA 19090

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM